On April 24, 2015, the Centers for Disease Control and Prevention (CDC) issued a Health Advisory to alert public health departments and health care providers of the possibility of human immunodeficiency virus (HIV) outbreaks among persons who inject drugs (PWID) and to provide guidance to assist in the identification and prevention of such outbreaks.
On April 9, 2015, Baxter International Inc. announced a voluntary recall of select lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter. IV administration of a solution containing sterile particulate matter may lead to adverse health consequences. The extent and severity of harm depends on the size, number, and composition of the foreign material, and patient’s underlying medical condition.
The American Nurses Association (ANA) Workplace Violence and Incivility Professional Issues Panel requests public comment on the Draft Position Statement: Incivility, Bullying, and Workplace Violence. Nurses, students, and other stakeholders are invited to review and comment on the document, which is intended to assist nurses and employers with understanding, defining, and mitigating/eliminating incivility, bullying, and violence in the workplace.
ANNA President-Elect Cindy Richards, BSN, RN, CNN, discusses how the increase in chronic kidney disease (CKD) is affecting the nephrology nursing specialty in an article for TravelNurses.com. Specifically, there will be an increased need for nephrology nurses to provide care in physician’s offices, in hospitals, and especially in dialysis units.
The Kidney Health Initiative (KHI) is requesting kidney disease patients and their families to provide input on potential future treatments and innovations. KHI, a partner of the U.S. Food and Drug Administration (FDA), facilitates the kidney community’s collaboration to enhance patient safety and foster innovation of drugs, devices, biologics, and food products.